What We Do

  • Disease landscaping and forecasting
  • Epidemiological studies
  • Pharma market tracking
  • Physician insights
  • Emerging therapies study
  • Industry insights
  • Company and drug insights
  • Product feasibility assessment
  • Patient needs and NPS
  • Doctor NPS diagnostic
  • Pharmacovigilance study
  • Real world and late stage research
  • Regulatory ecosystem
  • Channel partner NPS
  • Sales force effectiveness
  • Cost benchmarking
  • Micro-market expansion
  • Brand health diagnostic

Related Case Studies

Customer sub-segmentation for insulin delivery devices

Customer sub-segmentation for insulin delivery devices

Objective

  • An Indian insulin manufacturer wanted to understand customer archetypes and KPC (Key Purchase Criteria) for various insulin delivery devices like syringes, insulin pens, jet injectors, inhalers and pens 

Methodology

  • Conducted consumer survey (N = 600) and in-depth consumer interviews (N=25) in 4 weeks across 40 cities (mix of metro, tier 1 & 2 cities) for different customer archetypes and KPC (based on household types, age groups, employment status, gender, severity, type (Type – I or Type – II) and duration of disease 
  • Conducted trade interviews (N = 15) of distributors, stockists, pharmacists and retailers across product categories (syringes, insulin pens, inhalers and pumps) to understand KPC for customers and influencing power of trade in customer purchase 
  • Conducted IDIs (N = 25) with medical practitioners, diabetologists and endocrinologists to understand recommendation process for delivery device and degree of choice for the patient   
  • Carried out product and service benchmarking for key devices offered by key players to understand scope of differentiation for the client

Impact / Outcome

  • Client understood detailed insights on key consumer behaviour and preferences, key strengths and improvement areas for existing insulin delivery device players and process of recommendation by medical fraternity 
Mapping online drug purchase process and estimating NPS for chronic disease patients

Mapping online drug purchase process and estimating NPS for chronic disease patients

Objective

  • A top e-pharmacy company in India wanted to benchmark its performance across product features and touchpoints against its peers  

Methodology

  • Mapped customer journeys for offline and online drug purchase through customer interviews (N = 10) and mystery shopping?  
  • Conducted consumer survey (N = 1,200) and in-depth customer interviews (N = 25) in 6 weeks across 25 cities (Metro, Tier-I and Tier-II) to develop customer archetypes and capture NPS for online drug purchase across geographies, age-groups, chronic disease types (diabetes, hypertension, migraine etc.)  
  • Conducted competitor’s customer survey (N = 50) to understand detraction from client platform and identify areas of improvement 
  • Understood key competitors’ strengths and weaknesses by elaborate secondary research  
  • Deep-dived into performance and business journey of international players to find success analogs and sketch best practices for the client 

Impact / Outcome

  • Client understood detailed insights on key consumer behaviour and preferences, key strengths and improvement areas for other e-pharmacy players and improvement areas to improve its NPS 
Market potential estimation for H2-blocker for treatment of gastric ulcers

Market potential estimation for H2-blocker for treatment of gastric ulcers

Objective

  • A pharma player developed a next generation H2-blocker for the treatment of gastric ulcers. After showing strong sales and growth in EU5 markets, the company is now looking to expand the sales of the drug to South East Asia and wanted to understand market potential in these countries  

Methodology

  • Conducted in-depth study of intricate epidemiological data from proprietary databases for 5 countries to estimate disease incidence 
  • Combed through demographic data to understand affluence and estimate TAM (Total Addressable Market) 
  • Conducted In-Depth Interviews (N = 15) of medical practitioners to understand current modes of treatment of gastric ulcers  
  • Conducted In-Depth Interviews (N = 10) of ex-senior leadership in competitor companies to estimate future market potential for the client  
  • Conducted consumer survey (N = 600) and in-depth consumer interviews (N=25) in 4 weeks across 40 cities in 5 countries to estimate willingness to switch to client’s drug  
  • Carried out product and service benchmarking for key players offerings treatments for gastric ulcers currently 

Impact / Outcome

  • Client understood market potential in each of the 5 targeted countries along with a preliminary idea of SAM (Serviceable Addressable Market). An estimate of willingness to switch to client’s treatment country-wise was provided which subsequently helped the client prioritize market launch for the drug. 
Pharmacovigilance for a NSAID

Pharmacovigilance for a NSAID

Objective

  • A CRO (Contract Research Organization) wanted to capture huge amounts of data as part of its post-market safety monitoring study on a newly approved NSAID (Non-Steroidal Anti-Inflammatory Drug) by CDSCO 

Methodology

  • Conducted In-Depth Interviews (IDIs, N = 15) of medical practitioners to outline all possible physiological impacts of drug based on its pathway and pharmacokinetics across patient segments 
  • Conducted patient survey (N = 10,000) and in-depth patient interviews (N = 5,00) in 10 weeks across 40 cities (mix of metro, tier 1 & 2 cities) and different age-groups, genders, affluence and use cases for NSAID 
  • Conducted IDIs (N = 25) of channel partners (pharmacies and hospitals) to account for feedback from patients uncovered from survey  
  • Carried out social media listening for in-context NSAID to substantiate survey claims 
  • Drafted preliminary analysis of drug impact across patient age-groups, affluence, geography and use cases 

Impact / Outcome 

  • Client obtained elaborate data on patient results for the select NSAID across age-groups, affluence, geography and use cases. Preliminary feedback of drug performance across customer segments provided. 

We use cookies to improve your website experience. By navigating our site, you agree to allow us to use cookies, in accordance with our Cookie Policy